ROCK2 Regulates Invasion and Migration of Osteosarcoma Cells
10.3971/j.issn.1000-8578.2022.21.0562
- VernacularTitle:ROCK2调控骨肉瘤细胞的侵袭及迁移
- Author:
Wenhao SHAN
1
;
Weijiang YI
;
Sijun ZHANG
;
Wei JIANG
;
Jian XIA
Author Information
1. Department of Orthopedics, Nanchang First Hospital, Nanchang 330008, China
- Publication Type:Research Article
- Keywords:
ROCK2;
EMT;
Osteosarcoma;
Invasion;
Migration
- From:
Cancer Research on Prevention and Treatment
2022;49(2):95-100
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the expression of ROCK2 in osteosarcoma tissues and explore its effect on the invasion and migration of osteosarcoma cells and related mechanism. Methods Real-time fluorescent quantitative PCR, Western blot and immunohistochemical staining were used to detect the expression of ROCK2 in osteosarcoma tissues. The migration and invasion of osteosarcoma cells were analyzed by wound-healing and Transwell assays after the knockdown of ROCK2 expression. The effect of reducing ROCK2 expression on metastasis in vivo was tested by tail vein metastasis experiment. We detected the expression of EMT-related proteins in osteosarcoma cells, and added the EMT inducer TGF-β to osteosarcoma cells with down-regulated ROCK2 expression to detect the changes of cell invasion and migration. Results The expression of ROCK2 in osteosarcoma tissues was significantly higher than that in corresponding adjacent tissues (P < 0.05). After down-regulating the expression of ROCK2 in osteosarcoma cells, the invasion and migration abilities in vivo and in vitro were significantly inhibited (P < 0.05). The expression of EMT-related protein E-cadherin decreased, while N-cadherin and Vimentin proteins increased significantly. Inducing EMT could attenuate the inhibitory effect of down-regulating ROCK2 on the invasion and migration of osteosarcoma cells. Conclusion The expression of ROCK2 is increased in osteosarcoma tissues, which promotes the invasion and migration of osteosarcoma cells by inducing EMT. ROCK2 may be a potential biomarker for targeted therapy of osteosarcoma.
